荣昌生物2025年第三季度净利润亏损1.01亿元

Core Insights - Rongchang Bio reported a revenue of 622 million yuan for Q3 2025, representing a year-on-year growth of 33.13% [1] - The net profit attributable to shareholders for Q3 2025 was a loss of 101 million yuan [1] - For the first three quarters of 2025, the company achieved a total revenue of 1.72 billion yuan, marking a year-on-year increase of 42.27% [1] - The net profit attributable to shareholders for the first three quarters was a loss of 551 million yuan [1]